Alert detail

LCD L40249: MolDX: Molecular Testing for Solid Organ Allograft Rejection — WPS

Policy ID: LCD-L40249Specialty: Clinical LaboratoryAdded: 7/16/2026Effective: August 30, 2026lcd
Routine

What changed

WPS finalizes molecular allograft rejection testing coverage (eff. 8/30/26)

Who’s affected: Clinical Laboratory billing teams · Effective: August 30, 2026

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 12 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Clinical Laboratory— the week’s changes and deadlines, delivered to your inbox. No account required.

LCD L40249: MolDX: Molecular Testing for Solid Organ Allograft Rejection — WPS